Effect of rifabutin on ethambutol pharmacokinetics in healthy volunteers.
The effect of repeated administration of rifabutin on the pharmacokinetics and metabolism of ethambutol was evaluated in ten healthy volunteers. The subjects received a single oral administration of 1200 mg ethambutol on days 1 and 10 and a single daily oral dose of 300 mg rifabutin from days 3 to 9. No statistically significant difference was found in plasma pharmacokinetics (C(max), t(max), AUC, half-life and MRT) and in the renal clearance, whereas a significant decrease in the amount of unchanged ethambutol excreted in urine was observed. The decrease observed in ethambutol urinary excretion may be accounted for by taking into consideration the variability of the urinary excretion of ethambutol reported in the literature. However, a slight, likely not clinically relevant, induction or activation of kidney alcohol and/or aldehyde dehydrogenase isoenzymes by rifabutin cannot be ruled out at present. Evidence exists in the present study for autoinduction of rifabutin metabolism; this is shown by the lower plasma concentrations obtained 24 h after the seventh dose as compared to the theoretical concentrations.
Breda
M
M
Viale Pasteur 10, Pharmacia & UpJohn, Nerviano, Milan, 20014, Italy.
Benedetti
M S
MS
Bani
M
M
Pellizzoni
C
C
Poggesi
I
I
Brianceschi
G
G
Rocchetti
M
M
Dolfi
L
L
Sassella
D
D
Rimoldi
R
R
D000328:Adult; D000904:Antibiotics, Antitubercular / Q000097:blood / Q000494:pharmacology*; D000995:Antitubercular Agents / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D004359:Drug Therapy, Combination; D004977:Ethambutol / Q000097:blood / Q000493:pharmacokinetics* / Q000652:urine; D006801:Humans; D008297:Male; D008875:Middle Aged; D017828:Rifabutin / Q000097:blood / Q000494:pharmacology*
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D017828:Rifabutin; D004977:Ethambutol